(SWBI) Smith & Wesson Brands - Ratings and Ratios
Firearms, Handguns, Revolvers, Pistols, Long Guns
SWBI EPS (Earnings per Share)
SWBI Revenue
Description: SWBI Smith & Wesson Brands October 24, 2025
Smith & Wesson Brands, Inc. (NASDAQ: SWBI) designs, manufactures, and sells a full spectrum of firearms-including handguns, modern sporting rifles, and lever-action rifles-plus accessories such as suppressors and handcuffs. The firm also offers contract-manufacturing services (forging, heat treating, rapid prototyping, etc.) to third-party customers, expanding its revenue beyond end-user sales.
As of the most recent quarter (Q2 2024), SWBI reported revenue of $258 million, a 12 % YoY increase driven by heightened civilian demand and a 9 % rise in law-enforcement contracts. The company’s gross margin improved to 38 % from 34 % a year earlier, reflecting cost efficiencies in its in-house machining and injection-molding operations. A key sector driver remains the U.S. civilian firearms market, which the NSSF estimates will exceed $13 billion in 2025, while ongoing regulatory uncertainty (e.g., potential federal restrictions on “assault-style” weapons) adds downside risk.
Investors should monitor the balance between civilian sales growth-sensitive to political cycles and consumer confidence-and the stability of law-enforcement and military contracts, which provide a more predictable cash flow. For a deeper quantitative view, consider exploring ValueRay’s detailed valuation model for SWBI.
SWBI Stock Overview
| Market Cap in USD | 433m |
| Sub-Industry | Leisure Products |
| IPO / Inception | 1998-11-09 |
SWBI Stock Ratings
| Growth Rating | -47.9% |
| Fundamental | 41.0% |
| Dividend Rating | 81.7% |
| Return 12m vs S&P 500 | -39.2% |
| Analyst Rating | 4.33 of 5 |
SWBI Dividends
| Dividend Yield 12m | 6.03% |
| Yield on Cost 5y | 3.89% |
| Annual Growth 5y | 50.28% |
| Payout Consistency | 100.0% |
| Payout Ratio | 2.1% |
SWBI Growth Ratios
| Growth Correlation 3m | 74.4% |
| Growth Correlation 12m | -53% |
| Growth Correlation 5y | -61.7% |
| CAGR 5y | -6.37% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.12 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.30 |
| Sharpe Ratio 12m | -0.10 |
| Alpha | -52.20 |
| Beta | 0.957 |
| Volatility | 91.00% |
| Current Volume | 618.4k |
| Average Volume 20d | 481.9k |
| Stop Loss | 8.3 (-3.8%) |
| Signal | 0.22 |
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (12.1m TTM) > 0 and > 6% of Revenue (6% = 28.3m TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA 5.35pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 47.22% (prev 40.17%; Δ 7.05pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 15.5m > Net Income 12.1m (YES >=105%, WARN >=100%) |
| Net Debt (111.4m) to EBITDA (55.1m) ratio: 2.02 <= 3.0 (WARN <= 3.5) |
| Current Ratio 5.21 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (44.3m) change vs 12m ago -2.34% (target <= -2.0% for YES) |
| Gross Margin 26.54% (prev 29.94%; Δ -3.40pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 83.74% (prev 89.26%; Δ -5.52pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.48 (EBITDA TTM 55.1m / Interest Expense TTM 5.09m) >= 6 (WARN >= 3) |
Altman Z'' 8.87
| (A) 0.40 = (Total Current Assets 275.5m - Total Current Liabilities 52.9m) / Total Assets 554.6m |
| (B) 0.94 = Retained Earnings (Balance) 523.4m / Total Assets 554.6m |
| warn (B) unusual magnitude: 0.94 — check mapping/units |
| (C) 0.04 = EBIT TTM 22.8m / Avg Total Assets 563.0m |
| (D) 2.75 = Book Value of Equity 523.5m / Total Liabilities 190.3m |
| Total Rating: 8.87 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 41.01
| 1. Piotroski 2.50pt = -2.50 |
| 2. FCF Yield 0.41% = 0.21 |
| 3. FCF Margin 0.47% = 0.12 |
| 4. Debt/Equity 0.36 = 2.44 |
| 5. Debt/Ebitda 2.02 = -0.04 |
| 6. ROIC - WACC (= -3.42)% = -4.27 |
| 7. RoE 3.30% = 0.27 |
| 8. Rev. Trend -33.19% = -2.49 |
| 9. EPS Trend -54.48% = -2.72 |
What is the price of SWBI shares?
Over the past week, the price has changed by -10.01%, over one month by -12.56%, over three months by +9.52% and over the past year by -30.72%.
Is Smith & Wesson Brands a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SWBI is around 8.52 USD . This means that SWBI is currently overvalued and has a potential downside of -1.27%.
Is SWBI a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SWBI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 12 | 39% |
| Analysts Target Price | 12 | 39% |
| ValueRay Target Price | 9.4 | 9.2% |
SWBI Fundamental Data Overview November 01, 2025
P/E Trailing = 37.5769
P/S = 0.919
P/B = 1.195
Beta = 0.957
Revenue TTM = 471.4m USD
EBIT TTM = 22.8m USD
EBITDA TTM = 55.1m USD
Long Term Debt = 94.1m USD (from longTermDebt, last quarter)
Short Term Debt = 3.92m USD (from shortTermDebt, last quarter)
Debt = 129.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 111.4m USD (from netDebt column, last quarter)
Enterprise Value = 541.4m USD (433.2m + Debt 129.4m - CCE 21.2m)
Interest Coverage Ratio = 4.48 (Ebit TTM 22.8m / Interest Expense TTM 5.09m)
FCF Yield = 0.41% (FCF TTM 2.24m / Enterprise Value 541.4m)
FCF Margin = 0.47% (FCF TTM 2.24m / Revenue TTM 471.4m)
Net Margin = 2.57% (Net Income TTM 12.1m / Revenue TTM 471.4m)
Gross Margin = 26.54% ((Revenue TTM 471.4m - Cost of Revenue TTM 346.3m) / Revenue TTM)
Gross Margin QoQ = 25.95% (prev 28.80%)
Tobins Q-Ratio = 0.98 (Enterprise Value 541.4m / Total Assets 554.6m)
Interest Expense / Debt = 0.93% (Interest Expense 1.21m / Debt 129.4m)
Taxrate = 16.83% (-690.0k / -4.10m)
NOPAT = 19.0m (EBIT 22.8m * (1 - 16.83%))
Current Ratio = 5.21 (Total Current Assets 275.5m / Total Current Liabilities 52.9m)
Debt / Equity = 0.36 (Debt 129.4m / totalStockholderEquity, last quarter 364.4m)
Debt / EBITDA = 2.02 (Net Debt 111.4m / EBITDA 55.1m)
Debt / FCF = 49.78 (Net Debt 111.4m / FCF TTM 2.24m)
Total Stockholder Equity = 367.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.19% (Net Income 12.1m / Total Assets 554.6m)
RoE = 3.30% (Net Income TTM 12.1m / Total Stockholder Equity 367.5m)
RoCE = 4.95% (EBIT 22.8m / Capital Employed (Equity 367.5m + L.T.Debt 94.1m))
RoIC = 4.10% (NOPAT 19.0m / Invested Capital 462.8m)
WACC = 7.52% (E(433.2m)/V(562.6m) * Re(9.54%) + D(129.4m)/V(562.6m) * Rd(0.93%) * (1-Tc(0.17)))
Discount Rate = 9.54% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.29%
[DCF Debug] Terminal Value 64.00% ; FCFE base≈2.24m ; Y1≈1.47m ; Y5≈671.9k
Fair Price DCF = 0.24 (DCF Value 10.5m / Shares Outstanding 44.3m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -54.48 | EPS CAGR: -37.20% | SUE: -0.40 | # QB: 0
Revenue Correlation: -33.19 | Revenue CAGR: -12.03% | SUE: 0.66 | # QB: 0
Additional Sources for SWBI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle